Home - Products - Daptomycin


Daptomycin* is a lipopeptide antibiotic active against Gram-positive bacteria: Such as Staphylococcus aureus (including methicillinresistant isolates), Streptococcus pyogenes, Streptococcus agalactiae, Streptococcus dysgalactiae subsp.equisimilis, and Enterococcus faecalis (vancomycin-susceptible isolates only).


Indication:Used in the treatment of complicated skin and skin structure/soft-tissue infections caused by susceptible isolates of Gram-positive bacteria in adult and pediatric patients and treatment of patients with Staphylococcus aureus (including MRSAmethicilin- resistant strains) bacteremia, as well as right-sided endocarditis.

Application: Administered systemically as intravenous infusion or injection.

Product grades



No monograph for Daptomycin in either Ph. Eur or USP available

Manufacturing site

Xellia Pharmaceuticals Ltd., Budapest, Hungary

Release site

Xellia Pharmaceuticals Ltd., Budapest, Hungary

Site registered

EU GMP issued by Hungarian National Institute of Pharmacy


Regulatory documentation

US Type II Drug Master File (DMF)

US Drug Master File (DMF)

Packaging sizes

Packaging size can be discussed with your Sales Representative

Packaging material

Primary: Aluminum foil bag (laminated with polyethylene on the inner side and polyester on outer side) and heat-sealed

Secondary: Primary bag placed into second identical bag also heat-welded and labeled

Shelf life

3 years

Storage conditions

Below -20 °C (- 4°F)

*Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement.